Position in HIMS
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$13,273,362
-$17,685,840 QoQ
Shares Held
639,372
-32.9% QoQ
Ownership
0.276%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2022
17 quarters on record
Voting authority
Sole 100.ToString("F0")%
Shared 0.ToString("F0")%
None 0.ToString("F0")%
Common Shares in HIMS Over Time
Shares Held
Position Value (USD)
Derivatives in HIMS
reported options exposure · as of Mar 31, 2026CallValue
$5,190,000
CallShares
250,000
PutValue
$3,207,420
PutShares
154,500
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Mar 31, 2026BARCLAYS PLC holds $516,666,064 across 52 Drug Manufacturers - Specialty & Generic names. HIMS ranks #8 (2.6% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ZTS |
Zoetis Inc.
|
1,809,925 | $213,951,231 | |
| 2 | INDV |
Indivior Pharmaceuticals, Inc.
|
1,745,751 | $53,210,488 | |
| 3 | VTRS |
Viatris Inc
|
3,144,439 | $42,481,369 | |
| 4 | TEVA |
Teva Pharmaceutical Industries Ltd
|
1,400,671 | $42,188,210 | |
| 5 | UTHR |
UNITED THERAPEUTICS Corp
|
63,005 | $37,360,703 | |
| 6 | NBIX |
Neurocrine Biosciences Inc
|
243,984 | $32,142,450 | |
| 7 | AMLX |
Amylyx Pharmaceuticals, Inc.
|
971,854 | $13,508,770 | |
| 8 | HIMS |
Hims & Hers Health, Inc.
This page
|
639,372 | $13,273,362 |
All Filings in HIMS
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $3,207,420 | 154,500 | Put | Defined | 2026-05-15 | |
| 2026-03-31 | $5,190,000 | 250,000 | Call | Defined | 2026-05-15 | |
| 2026-03-31 | $13,273,362 | 639,372 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $30,959,202 | 953,471 | Shares | Sole | 2026-02-13 | |
| 2025-12-31 | $8,085,030 | 249,000 | Put | Sole | 2026-02-13 | |
| 2025-12-31 | $9,091,600 | 280,000 | Call | Sole | 2026-02-13 | |
| 2025-09-30 | $14,180,000 | 250,000 | Call | Sole | 2026-03-31 | |
| 2025-09-30 | $37,376,834 | 658,971 | Shares | Sole | 2026-03-31 | |
| 2025-06-30 | $30,641,746 | 614,679 | Shares | Sole | 2026-02-27 | |
| 2025-06-30 | $3,903,255 | 78,300 | Put | Sole | 2026-02-27 | |
| 2025-06-30 | $14,536,260 | 291,600 | Call | Sole | 2026-02-27 | |
| 2025-03-31 | $10,441,935 | 353,365 | Shares | Sole | 2026-03-17 | |
| 2025-03-31 | $1,229,280 | 41,600 | Call | Sole | 2026-03-17 | |
| 2024-12-31 | $11,056,208 | 457,246 | Shares | Sole | 2026-03-19 | |
| 2024-09-30 | $5,680,045 | 308,363 | Shares | Sole | 2026-03-31 | |
| 2024-06-30 | $5,676,055 | 281,132 | Shares | Sole | 2026-03-23 | |
| 2024-03-31 | $2,365,502 | 152,909 | Shares | Sole | 2026-03-24 | |
| 2023-12-31 | $2,979,960 | 334,827 | Shares | Sole | 2026-03-24 | |
| 2023-09-30 | $1,958,209 | 311,321 | Shares | Sole | 2026-03-26 | |
| 2023-06-30 | $5,510,844 | 586,260 | Shares | Sole | 2026-03-27 | |
| 2023-03-31 | $2,816,545 | 283,926 | Shares | Sole | 2026-03-30 | |
| 2022-12-31 | $208,889 | 32,588 | Shares | Sole | 2026-03-30 | |
| 2022-09-30 | $28,714 | 5,146 | Shares | Sole | 2022-11-03 | |
| 2022-06-30 | $27,596 | 6,092 | Shares | Sole | 2022-08-12 | |
| 2022-03-31 | $1,924 | 361 | Shares | Sole | 2022-05-16 | |
| No filing history on record for this holder in this stock. | ||||||